Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference45 articles.
1. Latest global cancer data: Cancer burden rises to 18.1 million new cases and 9.6 million cancer deaths in 2018. 12 September 2018; Available from:
https://www.iarc.fr/wp-content/uploads/2018/09/pr263_E.pdf
. Cited 30 Aug 2019.
2. Lung cancer clinical outcomes publication 2017 (for surgical operations performed in 2015). Royal College of Physicians. 2017.
3. Armoiry X, Tsertsvadze A, Connock M, Royle P, Melendez-Torres GJ, Souquet P, et al. Comparative efficacy and safety of licensed treatments for previously treated non-small cell lung cancer: a systematic review and network meta-analysis. PLoS One. 2018;13(7):e0199575.
4. Connock M, Armoiry X, Tsertsvadze A, Melendez-Torres GJ, Royle P, Andronis L, et al. Comparative survival benefit of currently licensed second or third line treatments for epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) negative advanced or metastatic non-small cell lung cancer: a systematic review and secondary analysis of trials. BMC Cancer. 2019;19(1):392.
5. Schmidt C. The benefits of immunotherapy combinations. Nature. 2017;552(7685):S67–9.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献